Table 2 Clinical outcomes after surgery
Severe group | Impaired group | Normal group | P value (p1 | p2) | |
|---|---|---|---|---|
In-hospital outcomes | n = 128 | n = 680 | n = 1224 | |
In-hospital mortality | 6 (4.7%) | 11 (1.6%) | 14 (1.1%) | 0.03 | 0.002 |
Circulatory morbidity | ||||
New onset of MI | 5 (3.9%) | 17 (2.5%) | 20 (1.6%) | 0.37 | 0.07 |
Low cardiac output | 25 (19.5%) | 55 (8.1%) | 50 (4.1%) | <0.001 | <0.001 |
IABP support | 25 (19.5%) | 55 (8.1%) | 50 (4.1%) | <0.001 | <0.001 |
Reoperation for bleeding | 3 (2.3%) | 11 (1.6%) | 15 (1.2%) | 0.56 | 0.29 |
Prolonged ventilation (>48 h) | 11 (8.6%) | 24 (3.5%) | 13 (1.1%) | 0.01 | <0.001 |
Stroke | 5 (3.9%) | 25 (3.7%) | 41 (3.3%) | 0.90 | 0.74 |
Acute renal failure | 4 (3.1%) | 10 (1.5%) | 15 (1.2%) | 0.19 | 0.08 |
DSWI | 5 (3.9%) | 13 (1.9%) | 20 (1.6%) | 0.16 | 0.07 |
Red blood cell transfusion | 24 (18.8%) | 89 (13.1%) | 165 (13.5%) | 0.09 | 0.10 |
Length of ICU stay (d) | 3.9 ± 1.9 | 1.9 ± 1.2 | 1.6 ± 1.1 | <0.001 | <0.001 |
Follow-up outcomes | n = 122 | n = 610 | n = 1103 | |
All-cause mortality | 11 (9.0%) | 45 (7.4%) | 73 (6.6%) | 0.53 | 0.32 |
Cardiac-cause deaths | 4 (4.3%) | 11 (1.8%) | 16 (1.5%) | 0.29 | 0.13 |
Repeat revascularization | 4 (3.3%) | 14 (2.3%) | 26 (2.4%) | 0.52 | 0.53 |